XML 16 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Revenues $ 374.7 $ 445.4 $ 815.7 $ 862.2
Operating expenses:        
Salaries and benefits 116.1 132.7 256.5 261.9
Supplies 110.1 123.4 239.4 238.4
Professional and medical fees 45.3 36.4 92.1 71.5
Lease expense 21.5 21.0 42.8 41.6
Other operating expenses 26.3 26.9 54.7 53.1
Cost of revenues 319.3 340.4 685.5 666.5
General and administrative expenses 25.3 23.3 48.1 45.0
Depreciation and amortization 23.4 19.1 45.2 37.9
Income from equity investments (2.5) (2.2) (4.5) (4.2)
Loss (gain) on disposals and deconsolidations, net 2.9 (8.2) 6.4 (7.6)
Grant funds (43.1) 0.0 (43.1) 0.0
Transaction and integration costs 4.9 6.2 10.4 8.2
Litigation settlement 0.0 0.0 1.2 0.0
Loss on debt extinguishment 0.0 11.7 0.0 11.7
Other income (0.2) (0.4) (1.7) (0.4)
Total operating expenses 330.0 389.9 747.5 757.1
Operating income 44.7 55.5 68.2 105.1
Tax receivable agreement expense 0.0 0.0 0.0 (2.4)
Interest expense, net (49.2) (46.4) (96.3) (88.4)
(Loss) income before income taxes (4.5) 9.1 (28.1) 14.3
Income tax (benefit) expense (0.6) 1.0 (15.8) 2.7
Net (loss) income (3.9) 8.1 (12.3) 11.6
Less: Net income attributable to non-controlling interests (28.6) (27.9) (47.7) (51.5)
Net loss attributable to Surgery Partners, Inc. (32.5) (19.8) (60.0) (39.9)
Less: Amounts attributable to participating securities (9.7) (8.8) (19.2) (17.3)
Net loss attributable to common stockholders $ (42.2) $ (28.6) $ (79.2) $ (57.2)
Net loss per share attributable to common stockholders        
Basic (in USD per share) $ (0.86) $ (0.59) $ (1.63) $ (1.19)
Diluted (in USD per share) [1] $ (0.86) $ (0.59) $ (1.63) $ (1.19)
Weighted average common shares outstanding        
Basic (shares) 48,840 48,291 48,661 48,241
Diluted (shares) [1] 48,840 48,291 48,661 48,241
[1] The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods.